๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Orion Corporation โ€” Licensed Medicines

35 medicines held by Orion Corporation on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 35 products held by Orion Corporation
MedicineActive substanceLicence holderStatus
Bufomix Easyhaler 160 micrograms/4.5 micrograms/inhalation, inhalation powder
PA1327/015/002
Budesonide, Formoterol fumarate dihydrate Orion Corporation Marketed
Bufomix Easyhaler 320 micrograms/9 micrograms/inhalation, inhalation powder
PA1327/015/003
Budesonide, Formoterol fumarate dihydrate Orion Corporation Marketed
Bufomix Easyhaler 80 micrograms/4.5 micrograms/inhalation, inhalation powder
PA1327/015/004
Budesonide, Formoterol fumarate dihydrate Orion Corporation Marketed
COMTESS 200 mg Film-coated tablet
EU/1/98/082/001
Orion Corporation โ€”
COMTESS 200 mg Film-coated tablet
EU/1/98/082/002
Orion Corporation โ€”
COMTESS 200 mg Film-coated tablet
EU/1/98/082/003
Orion Corporation โ€”
Corbilta 100 mg/25mg/200 mg film coated tablets
EU/1/13/859/012-017
Carbidopa monohydrate, Entacapone, Levodopa Orion Corporation โ€”
Corbilta 125 mg/31.25 mg/200 mg film-coated tablets
EU/1/13/859/018-022
Entacapone, Carbidopa monohydrate, Levodopa Orion Corporation โ€”
Corbilta 150 mg/37.5 mg/200 mg film-coated tablets
EU/1/13/859/023-028
Levodopa, Carbidopa monohydrate, Entacapone Orion Corporation โ€”
Corbilta 175 mg/43.75 mg/200 mg film-coated tablets
EU/1/13/859/029-033
Entacapone, Carbidopa monohydrate, Levodopa Orion Corporation โ€”
Corbilta 200 mg/50 mg/200 mg film-coated tablets
EU/1/13/859/034-038
Entacapone, Carbidopa monohydrate, Levodopa Orion Corporation โ€”
Corbilta 50 mg/12.5 mg/200 mg film-coated tablets
EU/1/13/859/001-006
Carbidopa monohydrate, Entacapone, Levodopa Orion Corporation โ€”
Corbilta 75 mg/18.75 mg/200 mg film-coated tablets
EU/1/13/859/007-011
Entacapone, Carbidopa monohydrate, Levodopa Orion Corporation โ€”
Dexdor 100 micrograms/ml concentrate for solution for infusion
EU/1/11/718/001-006
Dexmedetomidine hydrochloride Orion Corporation โ€”
Divigel 0.1% w/w Gel, 1 mg/dose
PA1327/002/001
Estradiol Orion Corporation Marketed
Eldepryl 5 mg Tablets
PA1327/003/001
Selegiline hydrochloride Orion Corporation Marketed
Entacapone Orion 200 mg film-coated tablets
EU/1/11/708/001-004
Entacapone Orion Corporation โ€”
Fareston 60 mg Tablets
EU/1/96/004/001
Toremifene citrate Orion Corporation โ€”
Fareston 60 mg Tablets
EU/1/96/004/002
Toremifene Orion Corporation โ€”
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg film-coated tablets
EU/1/11/706/012-017
Levodopa, Entacapone, Carbidopa monohydrate Orion Corporation โ€”
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg film-coated tablets
EU/1/11/706/018-022
Levodopa, Entacapone, Carbidopa monohydrate Orion Corporation โ€”
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg film-coated tablets
EU/1/11/706/023-028
Levodopa, Carbidopa monohydrate, Entacapone Orion Corporation โ€”
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg film-coated tablets
EU/1/11/706/034-38
Entacapone, Carbidopa monohydrate, Levodopa Orion Corporation โ€”
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg film-coated tablets
EU/1/11/706/029-033
Entacapone, Levodopa, Carbidopa monohydrate Orion Corporation โ€”
Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg film-coated tablets
EU/1/11/706/007-011
Levodopa, Carbidopa monohydrate, Entacapone Orion Corporation โ€”
Methotrexate Orion 10 mg tablets
PA1327/019/002
Methotrexate Orion Corporation Marketed
Methotrexate Orion 2.5 mg tablets
PA1327/019/001
Methotrexate Orion Corporation Marketed
Migsun 85 mg/500 mg film-coated tablets
PA1327/022/001
Sumatriptan succinate, Naproxen sodium Orion Corporation Marketed
Stalevo
EU/1/03/260/001-004,13,16
Carbidopa, Entacapone, Levodopa Orion Corporation โ€”
Stalevo
EU/1/03/260/005-008,14,17
Orion Corporation โ€”
Stalevo
EU/1/03/260/009-012,15,18
Orion Corporation โ€”
Stalevo 125 mg/31.25 mg/200 mg film-coated tablets
EU/1/03/260/29-33
Carbidopa monohydrate, Entacapone, Levodopa Orion Corporation โ€”
Stalevo 175 mg/43.75 mg/200 mg film-coated tablets
EU/1/03/260/034-038
Carbidopa, Entacapone, Levodopa Orion Corporation โ€”
Stalevo 200 mg/50 mg/200 mg film-coated tablets
EU/1/03/260/19-23
Carbidopa, Entacapone, Levodopa Orion Corporation โ€”
Stalevo 75 mg/18.75 mg/200 mg film-coated tablets
EU/1/03/260/24-28
Carbidopa monohydrate, Levodopa, Entacapone Orion Corporation โ€”

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.